1) Swerdlow, S. H. et al. (eds) : WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, IARC, Lyon, 2008
2) Arber, D. A. et al. : The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127 : 2391-2405, 2016
3) Swerdlow, S. H. et al. (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed), IARC, Lyon, 2017
4) Arock, M. et al. : KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis. Leukemia 29 : 1223-1232, 2015
5) Barbui, T. et al. : Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia. Leukemia 27 : 1953-1958, 2013
6) Klampfl, T. et al. : Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369 : 2379-2390, 2013
7) Nangalia, J. et al. : Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369 : 2391-2405, 2013
8) Rumi, E. et al. : JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood 123 : 1544-1551, 2014
9) Barbui, T. et al. : Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer J 5 : e337, 2015
10) Maxson, J.E. et al. : Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 368 : 1781-1790, 2013
11) Patnaik, M.M. et al. : Refractory anemia with ring sideroblasts and RARS with thrombocytosis. Am J Hematol 90 : 549-559, 2015
12) Meggendorfer, M. et al. : SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 120 : 3080-3088, 2012
13) Chang, T.Y. et al. : Bedside to bench in juvenile myelomonocytic leukemia : insights into leukemogenesis from a rare pediatric leukemia. Blood 124 : 2487-2497, 2014
14) Zoi, K. et al. : Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. Int J Hematol 101 : 229-242, 2015
15) Papaemmanuil, E. et al. : Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365 : 1384-1395, 2011
16) Yoshida, K. et al. : Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478 : 64-69, 2011
17) West, A. H. et al. : Familial myelodysplastic syndrome/acute leukemia syndromes : a review and utility for translational investigations. Ann N Y Acad Sci 1310 : 111-118, 2014